Bradley Shapiro, MD Named 2026 Castle Connolly Top Doctor for Gastroenterology Excellence

Bradley Shapiro, MD, has been named a 2026 Castle Connolly Top Doctor, marking the second year he has received this designation. Only 7 percent of the nation's licensed physicians are chosen annually as Castle Connolly Top Doctors for their specialties in their regions. Dr. Shapiro is a gastroenterologist with Duly Health and Care, a leading multi-specialty practice providing comprehensive, patient-centered healthcare services across the suburban Chicago area. He has been part of the organization since September 2017 and has offered specialized gastrointestinal care to the community for over two decades.

Dr. Shapiro evaluates and treats a wide range of primary gastrointestinal conditions. His medical focus includes managing esophageal and swallowing disorders such as GERD, Barrett's and eosinophilic esophagitis, along with colorectal screening and surveillance. He also addresses complex digestive issues including Crohn's disease and ulcerative colitis. As a specialist in gastroenterology, Dr. Shapiro performs several key procedures to diagnose and treat digestive health disorders, including colonoscopy with polyp resection, upper endoscopy (EGD), dilation for esophageal strictures, and esophageal pH and motility studies.

Dr. Shapiro's extensive medical education and training began at the University of Michigan, where he earned his Bachelor of Science with distinction in 1986, followed by his medical degree from the University of Michigan Medical School in 1990. He completed his internal medicine internship at Northwestern Memorial Hospital in 1991. He then performed his internal medicine residency at Rush University Medical Center from 1991 to 1993, where he later served as a Clinical Instructor of Internal Medicine. Dr. Shapiro completed his advanced specialized training with a Gastroenterology Fellowship at The Cleveland Clinic Foundation, where he served as Chief Fellow.

Throughout his career, Dr. Shapiro has contributed significantly to medical research and academia. He is a published author in several peer-reviewed journals, including the American Journal of Gastroenterology and Modern Pathology, with specific research emphasis on p53 suppressor gene mutations as markers for cancer in ulcerative colitis. He has been a diplomate of the National Board of Medical Examiners since 1991 and holds board certifications in Gastroenterology and Internal Medicine. His professional excellence has been recognized with numerous honors, including the American College of Gastroenterology Research Grant and several Vitals Compassionate Doctor awards.

Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team. Castle Connolly publishes its Top Doctors list at https://castleconnolly.com and in various print and online partner publications. Nominations are open to all board-certified MDs, DOs, and DPMs. The Castle Connolly team chooses honorees based on nominee criteria that includes their medical education, training, hospital appointments, and disciplinary histories. Doctors do not and cannot pay to be selected as a Castle Connolly Top Doctor.